HM15211
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)
Hanmi · Phase 1 · Completed · Enrollment 41
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.